• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定与Abl和rasGAP相关的62 kDa蛋白为对接蛋白Dok。

Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok.

作者信息

Yamanashi Y, Baltimore D

机构信息

Department of Biology, Massachusetts Institute of Technology, Cambridge 02139, USA.

出版信息

Cell. 1997 Jan 24;88(2):205-11. doi: 10.1016/s0092-8674(00)81841-3.

DOI:10.1016/s0092-8674(00)81841-3
PMID:9008161
Abstract

A 62 kDa protein is highly phosphorylated in many cells containing activated tyrosine kinases. This protein, characterized mainly by its avid association with rasGAP, has proved elusive. Anti-phosphotyrosine antibody was used to purify p62. From peptide sequence, molecular cloning revealed a cDNA encoding a novel protein, p62dok, with little homology to others but with a prominent set of tyrosines and nearby sequences suggestive of SH2 binding sites. In cells, v-Abl tyrosine kinase binds and strongly phosphorylates p62dok, which then binds rasGAP. A monoclonal antibody, 2C4, to the rasGAP-associated p62 reacts with p62dok. Thus, p62dok appears to be the long-sought major substrate of many tyrosine kinases.

摘要

一种62 kDa的蛋白质在许多含有活化酪氨酸激酶的细胞中高度磷酸化。这种主要以与rasGAP紧密结合为特征的蛋白质一直难以捉摸。抗磷酸酪氨酸抗体被用于纯化p62。通过肽序列分析,分子克隆揭示了一个编码新型蛋白质p62dok的cDNA,它与其他蛋白质几乎没有同源性,但有一组突出的酪氨酸以及附近提示SH2结合位点的序列。在细胞中,v-Abl酪氨酸激酶结合并强烈磷酸化p62dok,然后p62dok结合rasGAP。一种针对与rasGAP相关的p62的单克隆抗体2C4可与p62dok发生反应。因此,p62dok似乎是许多酪氨酸激酶长期以来寻找的主要底物。

相似文献

1
Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok.鉴定与Abl和rasGAP相关的62 kDa蛋白为对接蛋白Dok。
Cell. 1997 Jan 24;88(2):205-11. doi: 10.1016/s0092-8674(00)81841-3.
2
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins.p56dok-2的分子克隆与特性鉴定确定了一个新的RasGAP结合蛋白家族。
J Biol Chem. 1998 Feb 27;273(9):4827-30. doi: 10.1074/jbc.273.9.4827.
3
Characterization of a novel member of the DOK family that binds and modulates Abl signaling.一种结合并调节Abl信号传导的DOK家族新成员的特性分析。
Mol Cell Biol. 1999 Dec;19(12):8314-25. doi: 10.1128/MCB.19.12.8314.
4
Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins.p62(dok)与p210(bcr-abl)及Bcr-Abl相关蛋白的相互作用。
J Biol Chem. 1998 Nov 27;273(48):32360-8. doi: 10.1074/jbc.273.48.32360.
5
Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.p210bcr-abl对p62dok的酪氨酸磷酸化会抑制RasGAP活性。
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2093-8. doi: 10.1073/pnas.040547997.
6
Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt.胰岛素受体介导的p62dok在362位和398位残基处的酪氨酸磷酸化在结合GTP酶激活蛋白和Nck方面发挥不同作用,并且对于抑制胰岛素刺激的Ras和Akt激活至关重要。
J Biol Chem. 2001 Nov 16;276(46):42843-50. doi: 10.1074/jbc.M102116200. Epub 2001 Sep 10.
7
p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.p62(dok):慢性粒细胞白血病祖细胞中一种组成型酪氨酸磷酸化的、与GAP相关的蛋白。
Cell. 1997 Jan 24;88(2):197-204. doi: 10.1016/s0092-8674(00)81840-1.
8
The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.Tek/Tie2受体通过一种新型的与Dok相关的对接蛋白Dok-R发出信号。
Oncogene. 1998 Sep 3;17(9):1097-108. doi: 10.1038/sj.onc.1202115.
9
The human p62 cDNA encodes Sam68 and not the RasGAP-associated p62 protein.人类p62 cDNA编码Sam68,而非与RasGAP相关的p62蛋白。
Cell. 1996 Jan 12;84(1):23-4. doi: 10.1016/s0092-8674(00)80989-7.
10
Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation.新型p62dok家族成员dok-4和dok-5是c-Ret受体酪氨酸激酶的底物,并介导神经元分化。
J Cell Biol. 2001 Jul 23;154(2):345-54. doi: 10.1083/jcb.200102032.

引用本文的文献

1
PTPN11 in cartilage development, adult homeostasis, and diseases.蛋白酪氨酸磷酸酶非受体型11在软骨发育、成人内稳态及疾病中的作用
Bone Res. 2025 May 16;13(1):53. doi: 10.1038/s41413-025-00425-0.
2
DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing.DOK1 和 DOK2 调节 CD8 T 细胞信号转导和记忆形成,而不影响肿瘤细胞杀伤。
Sci Rep. 2024 Jul 1;14(1):15053. doi: 10.1038/s41598-024-66075-0.
3
A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway.
PTP1B-Cdk3 信号轴通过 Rb-E2F 依赖性途径促进人胶质母细胞瘤细胞的细胞周期进程。
Mol Cell Biol. 2023;43(12):631-649. doi: 10.1080/10985549.2023.2273193. Epub 2023 Dec 20.
4
Microautophagy regulated by STK38 and GABARAPs is essential to repair lysosomes and prevent aging.由 STK38 和 GABARAPs 调控的微自噬对于修复溶酶体和预防衰老至关重要。
EMBO Rep. 2023 Dec 6;24(12):e57300. doi: 10.15252/embr.202357300. Epub 2023 Nov 21.
5
Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7.利用腺相关病毒9型-肌特异性肌酸激酶启动子驱动的DOK7(AAV9-tMCK-DOK7)在小鼠中长期进行肌肉特异性的DOK7过表达。
Mol Ther Nucleic Acids. 2023 Aug 2;33:617-628. doi: 10.1016/j.omtn.2023.07.036. eCollection 2023 Sep 12.
6
Seeking a better understanding of the non-receptor tyrosine kinase, SRMS.寻求对非受体酪氨酸激酶SRMS的更深入了解。
Heliyon. 2023 May 20;9(6):e16421. doi: 10.1016/j.heliyon.2023.e16421. eCollection 2023 Jun.
7
Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors.人类肿瘤中DOK家族基因表达、免疫特征及药物敏感性的综合分析
J Adv Res. 2021 Jun 12;36:73-87. doi: 10.1016/j.jare.2021.06.008. eCollection 2022 Feb.
8
Bottom-up reconstitution of focal adhesion complexes.从头组装黏着斑复合物。
FEBS J. 2022 Jun;289(12):3360-3373. doi: 10.1111/febs.16023. Epub 2021 May 30.
9
DOK7 Inhibits Cell Proliferation, Migration, and Invasion of Breast Cancer via the PI3K/PTEN/AKT Pathway.DOK7通过PI3K/PTEN/AKT信号通路抑制乳腺癌细胞的增殖、迁移和侵袭。
J Oncol. 2021 Jan 22;2021:4035257. doi: 10.1155/2021/4035257. eCollection 2021.
10
CD200-CD200R signaling and diseases: a potential therapeutic target?CD200-CD200R信号传导与疾病:一个潜在的治疗靶点?
Int J Physiol Pathophysiol Pharmacol. 2019 Dec 15;11(6):297-309. eCollection 2019.